Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)

for
Leukemia, B-Cell
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 1 - 25

Code: NCT05010564

Phase 1, Recruiting

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06302621

Phase 1, Recruiting

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

for
Leukemia, Lymphoma, Multiple Myeloma,
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 19+

Code: NCT04898790

Recruiting

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for
Advanced Cancer, Metastatic Cancer
Location: Morristown NJ, Jacksonville FL, Chicago IL,
Sponsor: Qurient Co., Ltd.

Sex: All

Age: 18+

Code: NCT05394103

Phase 1, Phase 2, Recruiting

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Solid Tumor
Location: New Haven CT, New York NY, Hackensack NJ, Miami FL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05981703

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Salt Lake City UT,
Sponsor: Peel Therapeutics Inc

Sex: All

Age: 18+

Code: NCT05329103

Phase 1, Recruiting

Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery

for
Malignant Abdominal Neoplasm, Malignant Head and Neck Neoplasm,
Location: Houston TX
Sponsor: Lucid Lane, Inc

Sex: All

Age: 18+

Code: NCT04963972

Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

for
Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer,
Location: Houston TX, Beverly Hills CA, Santa Monica CA
Sponsor: Epkin

Sex: All

Age: 18+

Code: NCT06789172

Phase 1, Recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

for
Advanced Cancer, Metastatic Solid Tumor
Location: Cleveland OH
Sponsor: Biocity Biopharmaceutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT06548672

Phase 1, Recruiting

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

for
Metabolic Disorders,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 0 - 20

Code: NCT00920972

Phase 1, Phase 2, Recruiting

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

for
Solid Tumors
Location: Boston MA, Montreal, Durham NC, Toronto, Atlanta GA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05203172

Phase 4, Recruiting

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

for
Epstein-Barr Virus Infections, Lymphoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT03258567

Phase 2, Recruiting

Testicular Tissue Cryopreservation for Fertility Preservation

for
Cancer, Autoimmune Disorders
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Male

Age: 0+

Code: NCT02972801

Recruiting

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

for
Pulmonary Hemorrhage, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05053867

Phase 3, Recruiting

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

for
Prostate Cancer,
Location: New York NY, Philadelphia PA
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT00503646

Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase 1, Phase 2, Recruiting

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Atlanta GA, Louisville KY, Fairway KS, Dallas TX,
Sponsor: Impact Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04768868

Phase 1, Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

for
Solid Tumors, ER+ Breast Cancer,
Location: Detroit MI, St Louis MO, Dallas TX, Salt Lake City UT
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT05490472

Phase 1, Phase 2, Recruiting

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Providence RI, East Brunswick NJ, Toronto, Sarasota FL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05875168

Phase 1, Phase 2, Recruiting

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

for
Benign Lymphoproliferative Disorder
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 0 - 70+

Code: NCT00001350

Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial